The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Asset accumulation, interdependence and technological change: evidence from pharmaceutical drug discovery
Abstract
Although the resource‐based view of the firm has been written about extensively, the process by which firm assets are accumulated has not been explored in detail. That is, we know little about the micro‐level mechanisms by which assets are built, nor do we have sufficient empirical evidence why some assets are more difficult to imitate, trade, or substitute. In this exploratory paper, we attempt to provide a better understanding of asset accumulation via an empirical research program in pharmaceutical drug discovery. Using a combination of field research, discovery data from nine pharmaceutical firms, and data on 218 alliances involving new technologies for experimentation and testing, three causes affecting asset accumulation are identified and described. First, the difficulty of imitating a particular asset is affected by interdependencies with other assets. Second, trading of assets can be impeded by structural inertia in the core of a firm that is adopting the technology asset. And third, fully specifying all factors affecting imitation and trading ex ante is very difficult, if not nearly impossible, under conditions of rapid technological change. We propose that the complex interactions of these causes can give rise to imperfections in factor markets. Finally, implications for further research are discussed as well. Copyright © 2002 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Firm Resources and Sustained Competitive Advantage
Barney, J. (1991) · Journal of Management · doi:10.1177/014920639101700108 · Cited by 48,334
Strategic assets and organizational rent
Amit, R., & Schoemaker, P. J. H. (1993) · Strategic Management Journal · doi:10.1002/smj.4250140105 · Cited by 8,425
Teece, D. J. (1986) · Research Policy · doi:10.1016/0048-7333(86)90027-2 · Cited by 7,842
Exploring internal stickiness: Impediments to the transfer of best practice within the firm
Szulanski, G. (1996) · Strategic Management Journal · doi:10.1002/smj.4250171105 · Cited by 7,839
Strategic Factor Markets: Expectations, Luck, and Business Strategy
Barney, J. B. (1986) · Management Science · doi:10.1287/mnsc.32.10.1231 · Cited by 5,548
Cited by
Managing Firm Resources in Dynamic Environments to Create Value: Looking Inside the Black Box
Sirmon, D. G., Hitt, M. A., & Ireland, R. D. (2007) · Academy of Management Review · doi:10.5465/amr.2007.23466005 · Cited by 3,701
Wilden, R., & Gudergan, S. P. (2015) · Journal of the Academy of Marketing Science · doi:10.1007/s11747-014-0380-y · Cited by 631
Eddleston, K. A., Kellermanns, F. W., & Sarathy, R. (2008) · Journal of Management Studies · doi:10.1111/j.1467-6486.2007.00717.x · Cited by 606
Capability Reconfiguration: An Analysis Of Incumbent Responses To Technological Change
Lavie, D. (2006) · Academy of Management Review · doi:10.5465/amr.2006.19379629 · Cited by 578
Patent Protection, Complementary Assets, and Firms’ Incentives for Technology Licensing
Arora, A., & Ceccagnoli, M. (2006) · Management Science · doi:10.1287/mnsc.1050.0437 · Cited by 542
Metadata
- Authors
- Thomke, S., & Kuemmerle, W.
- Venue
- Strategic Management Journal
- Publisher
- Wiley
- Published
- 2002-03-28
- Volume
- 23
- Issue
- 7
- Pages
- 619-635
- ISSN
- 0143-2095 (ISSN-L)
- 1097-0266
- OpenAlex
- W2083198283
- Cited by
- 183
- References
- 5
- FWCI
- 23.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Asset accumulation, interdependence and technological change: evidence from pharmaceutical drug discovery. https://app.cochat.ai/papers/10.1002/smj.242
- The paper
- Thomke, S., & Kuemmerle, W. (2002). Asset accumulation, interdependence and technological change: evidence from pharmaceutical drug discovery. Strategic Management Journal. https://doi.org/10.1002/smj.242
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.